Several patient populations have been identified as high risk for extubation failure despite successful completion of a spontaneous breathing trial (SBT). Extubation failure and subsequent need for emergent re-intubation have been associated with increased morbidity and mortality. In this review, we discuss ways to optimize the value and performance of the SBT in a subgroup of high-risk patients (elderly, cardiac, and/or respiratory failure) to reduce the rate of extubation failure. We recommend the use of T-piece mode, longer duration SBT, and measurement of the rapid shallow breathing index (breathing frequency/tidal volume in L) off ventilatory support to increase the predictive value of the SBT. In addition, measurement of changes in central venous oxygen saturation and serum brain natriuretic peptide, and measurements of mitral inflow and annular velocity using bedside transthoracic echocardiography with tissue Doppler imaging may help guide the clinician in determining who and when to extubate and thus minimize the rate of extubation failure. Arterial blood gas analysis performed at the end of the SBT may help determine who will benefit from prophylactic use of noninvasive ventilatory support postextubation.
Introduction
Liberating critically ill patients from mechanical ventilation typically involves a daily assessment of their respiratory status, improvement in the clinical issues that necessitated ventilatory support, decreased sedation, and performance of a spontaneous breathing trial (SBT). Use of a weaning protocol that incorporates a daily SBT became common in clinical practice following a randomized controlled trial that showed a shorter duration of mechanical ventilation (4.5 vs 6 d) and fewer complications compared to clinician-guided weaning. 1 Although the majority of patients with acute respiratory failure who pass an SBT will easily wean from ventilatory support, postextubation respiratory failure may develop in ϳ10 -25% of patients. [2] [3] [4] [5] [6] [7] [8] [9] [10] Extubation failure, irrespective of the baseline severity of the underlying illness, has been shown to be associated with higher morbidity and mortality. 2, 3 The mortality rate in re-intubated patients is as high as 43% compared to only 12% in those successfully extubated. 3 Complications associated with the re-intubation process such as cardiac arrest, arrhythmias, and aspiration pneumonia may occur in up to 28% of patients. 2 Patients who require re-intubation also have an increased risk of developing pneumonia and sepsis. 7, 10, 11 Frutos-Vivar et al 7 reported that 31% of re-intubated subjects developed ventilator-associated pneumonia, and 21% developed sepsis. Re-intubated patients have longer ICU and hospital stays and increased transfer rates to long-term acute care facilities. 3 Several risk factors for extubation failure have been identified in prior studies. These risk factors include impaired neurological status, poor cough, increased secretions, peak expiratory flow Յ 60 L/min, hemoglobin Յ 100 g/L, rapid shallow breathing index (RSBI; breathing frequency/tidal volume in L) of Ͼ 105, high Acute Physiology and Chronic Health Evaluation II score at time of weaning, and a positive fluid balance state. 3, 8, [12] [13] [14] [15] [16] Patients who are elderly 3, 10 or patients with chronic respiratory 10, 12, 17 and/or cardiac 3,10 diseases have generally been identified in a number of studies as a high-risk-for-failure (HRFF) population who are at increased risk for extubation failure and therefore are at increased risk for morbidity and mortality. In patients Ͼ 65 y of age with chronic respiratory and/or cardiac disease, the re-intubation rate is 34% compared to 9% in younger patients without these risk factors. 10 Patients who fail weaning due to respiratory failure and congestive heart failure have a higher mortality rate than those who fail due to airway-related causes, such as upper airway obstruction, aspiration, or increased secretions (53% vs 17%). 2 In this review, our focus is on how to optimize the value and performance of SBTs in HRFF patients to improve the predictive value of the test and therefore reduce extubation failure rate. Clinical trials focusing specifically on the HRFF population are very limited; therefore, the recommendations provided are our own based on the available evidence. Although not discussed here, there may be other populations considered to be HRFF for whom our recommendations may be applicable, such as patients with neuromuscular weakness or prolonged mechanical ventilator dependence. [18] [19] [20] 
Cardiopulmonary Interactions and Physiology
During SBT and Postextubation
There are many changes in the cardiopulmonary physiology that occur during the transition from positive-pressure supported to negative-pressure unsupported spontaneous breathing. The success of weaning depends on the ability of the respiratory system and cardiac pump to tolerate these changes. Postextubation, patients may experience an increase in ventilatory load on respiratory muscles due to bronchospasm, glottic edema, increased airway secretions, and/or sputum retention. 2, 21 Patients with COPD can develop intrinsic PEEP and dynamic hyperinflation. 22 Intrinsic PEEP can decrease venous return to the right heart, increase right ventricular afterload, and increase pulmonary vascular resistance, which can result in right ventricular failure. 23 Dynamic hyperinflation increases the work of breathing by affecting the efficiency of diaphragmatic and respiratory muscle function. Transfer from positive-pressure ventilation to spontaneous ventilation is associated with increased cardiac venous return (preload) and increased left ventricular afterload from the negative intrathoracic pressure generation. 24 In patients with coronary artery disease, this could induce myocardial ischemia, 25 and in those with cardiac compromise, this could result in decreased forward flow and impaired perfusion and precipitate cardiac failure or cardiogenic shock. 26 Once their acute illness has resolved, most patients are able to tolerate any increase in airway resistance and hemodynamic changes associated with spontaneous breathing. 4 However, patients with COPD and congestive heart failure may not sustain their breathing in the face of this increased work load if they are extubated prematurely. Tobin 27 stated, "If there is any reason to fear that a patient might experience respiratory difficulties following extubation, it is incumbent on a physician to try to replicate the conditions that the patient will face after extubation but do so before removal of the endotracheal tube." The SBT is the time to identify the patients who are not ready to be extubated. In one study, subjects failing an SBT were noted to have increased gastric mucosal ischemia (decreased gastric intramucosal pH, a marker of splanchnic hypoperfusion) and a decline in central venous oxygen (a marker of decreased oxygen delivery or increased consumption) levels compared to those with successful weaning. 28, 29 A marked increase in the pulmonary artery occlusion pressure and left ventricular diastolic volume index was observed in patients with severe COPD and cardiovascular disease who failed weaning trials. After appropriate diuresis, patients were successfully weaned without a change in pulmonary artery occlusion pressure. 26 Therefore, with an optimal SBT and close monitoring of respiratory and cardiac indices, one will likely be able to identify signs of cardiopulmonary failure in patients who are not ready to be extubated. It is particularly helpful in the HRFF patient population to replicate the mode and duration of SBT as close to the conditions the patient will face postextubation.
SBT Using a T-Piece Is Better Than Minimal Pressure Support for HRFF Patients
An SBT can be performed with patients breathing through the endotracheal or tracheostomy tube without any ventilatory support (ie, through a T-piece) or with minimal ventilatory support (ie, low-level pressure support, automatic tube compensation, and/or CPAP). It has become common practice to perform an SBT with minimal pressure support because it requires less monitoring since the patient remains connected to the ventilator with the associated alarms and back-up ventilation if needed. In addition, in a randomized controlled clinical trial comparing SBT using a T-piece versus pressure support ventilation (PSV), a higher percentage of subjects in the PSV group passed the SBT (22% vs 14%), and there was no difference in the re-intubation rate. 4 Similarly, studies comparing T-piece to automatic tube compensation 30 and T-piece to CPAP 31 showed no difference in re-intubation rates. However, these clinical studies were limited due to the small number of subjects, and the study designs were not powered to detect a difference in the HRFF population.
The rational for performing an SBT with minimal ventilatory support is to overcome the increased airway resistance imposed by the endotracheal tube, which may contribute to weaning failure. However, this assumption fails to account for the common occurrence of upper airway edema or laryngeal lesions, 32 which could impose additional work load on patients after extubation. Experimental studies have shown that the work of breathing measured at the end of a 2-h T-piece trial is equivalent to postextubation respiratory load. 21 Use of any level of pressure support decreases the inspiratory load significantly. In a small study of subjects with acute respiratory failure of various etiologies, the use of CPAP (5 cm H 2 O) and PSV (5 cm H 2 O) decreased the work of breathing by 40% and 36%, respectively, compared to a T-piece. 33 In a study of difficult-to-wean subjects who failed a T-piece SBT trial, 57% and 79% passed when placed on PSV (7 cm H 2 O) or PSV ϩ PEEP (7 and 5 cm H 2 O), respectively. 34 Left ventricular heart failure was observed in 70% of these subjects during a T-piece trial, but only in 50% using PSV and 30% using PSV ϩ PEEP. 34 These studies demonstrate the potential for minimal ventilatory support during an SBT to enhance the patient's ability to successfully complete the trial. The physiological evidence shows that use of any mode other than T-piece does not simulate postextubation conditions. Use of any support in HRFF patients during the SBT may mask a significant risk for cardiopulmonary compromise, leading to extubation failure once the endotracheal tube is removed and the patient is liberated from ventilatory support. However, we recognize that there are no clinical studies to support this argument. It is possible that use of a T-piece may, in some patients, lead to increased false negatives (failing the SBT when they are truly ready to extubate) and therefore unnecessarily prolong mechanical ventilation. However, in conjunction with a T-piece, we believe that with appropriate patient selection (HRFF patients), proper clinical judgment, and utilization of additional diagnostic tools, we will be able to decrease the rate of extubation failure without increasing the risk of prolonged mechanical ventilation.
In HRFF Patients, Weaning Predictors Should Be Assessed Without Pressure Support During the SBT
Weaning predictors (objective physiologic measurements) used to assess readiness to liberate from a ventilator may also be affected by the mode of ventilation. Yang and Tobin 35 analyzed multiple variables to assess their usefulness in predicting weaning outcomes. They concluded that an RSBI of Ͻ 105 measured with a handheld spirometer attached to a breathing tube before an SBT was the most accurate predictor of weaning outcome. The RSBI measured in this manner had a sensitivity of 97% in predicting weaning success defined as both successful SBT and not requiring re-intubation within 24 h. The falsepositive rate was 36%. 35 In routine practice, the RSBI is measured before the SBT (to determine who would benefit from an SBT) and during the SBT (to determine who can be successfully extubated). The use of PSV or PEEP during the SBT could lower the patient's RSBI significantly and influence the physician's decision in favor of extubation. In a study comparing varying approaches to an SBT in a difficult-to-wean population (failed the first SBT attempt), the median RSBI was 92 during a T-piece trial compared to 89 during a PSV trial and 58 during a PSV ϩ PEEP SBT. 34 In a general group of ventilated subjects considered ready to undergo an extubation trial by their ICU team, 100% had an RSBI of Ͻ 105 during a PSV and CPAP SBT. However, 36% had an RSBI of Ͼ 105 when placed on a T-piece for the SBT. 36 Another study with a significant number of HRFF subjects (congestive heart failure was present in 56.2% and COPD in 52.5% of subjects) compared CPAP to a T-piece. Using 5 and 0 cm H 2 O CPAP, 35% and 26% of the RSBI, respectively, were erroneously deemed adequate for extubation compared to a T-piece. 37 The lower RSBI seen with 0 cm H 2 O CPAP was attributed to the base flow delivered by several modern ventilators, which provides a small amount of pressure support. 37 Recently, there has been an increased interest in assessing breath-to-breath breathing pattern variability as another predictor of successful weaning. Patients with decreased breathing pattern variability have been shown to have a higher incidence of extubation failure. 38, 39 Use of any type of pressure support has been shown to reduce the predictive performance of breathing pattern variability compared to T-piece weaning in a general group of ICU patients. 40 Therefore, the use of a threshold RSBI of 105 or assessing breathing pattern variability during an SBT using PSV or CPAP mode may provide a false assurance that the patient is ready to be liberated from ventilatory support and could result in premature discontinuation. However, the evidence is limited, as the studies did not evaluate extubation outcomes and were not focused specifically on the HRFF population. Regardless, the implications would be expected to be more pronounced in this population. These notions need to be confirmed in clinical studies focusing on HRFF patients.
Longer Weaning Trials May Be Considered for HRFF Patients
Earlier studies performed SBT for durations of at least 2 h. 41, 42 However, 2 randomized studies comparing SBT for a duration of 30 -120 min in all ventilated subjects ready to be weaned showed no difference in the rate of re-intubation between the groups. 5, 43 These findings have resulted in the use of shorter duration SBT in clinical practice. It is noteworthy that these studies had a small number of HRFF subjects. Therefore, the validity of these findings in an HRFF population is unknown, and the results should be extrapolated with caution in this population. In the study by Esteban et al, 5 although there was no statistically significant difference in the number of subjects failing the SBT, the median time to fail was less in the 30-min SBT group compared to the 120-min SBT group (15 vs 30 min, respectively). One explanation for this discrepancy could be a difference in the baseline risk factors in favor of the 30-min SBT group. In an observational study of ventilated subjects who failed an SBT, 40% of those with COPD failed between 30 and 120 min. 14 In an elderly population (Ն 70 y of age) in which 67% had cardiac disease and 36% had COPD, an 8-h SBT followed by a 2-h SBT the next day compared to a 2-h SBT alone significantly decreased the re-intubation rate (7.5% vs 48%). 44 Even though data supporting a longer SBT are limited, it may be prudent to err on the side of caution and recommend a 2-h SBT in the HRFF population.
Other Methods to Assess HRFF Patients
Successful weaning from mechanical ventilation depends not only on adequate respiratory strength and endurance, but also on optimal cardiac performance. 45 The weaning parameters commonly used in clinical practice assess only the respiratory load during an SBT and do not assess the imposed load on the heart. Studies have shown that measurements of central venous oxygen and serum brain natriuretic peptide (BNP) during an SBT could be useful tools to predict extubation failure due to cardiovascular dysfunction. [46] [47] [48] In a group of difficult-to-wean patients (failed the first weaning attempt), a decline in central venous oxygen by 4.5% between baseline and a 30-min SBT predicted extubation failure with a sensitivity of 88%, specificity of 95%, positive predictive value of 93%, and negative predictive value of 90%. 48 In a prospective observational study (55% of subjects had COPD), an aminoterminal pro-BNP level of Ͻ 1,000 pg/mL ruled out postextubation respiratory distress with 95% sensitivity and a negative likelihood ratio of 0.09. 47 In a study of subjects with acute respiratory failure from pneumonia or COPD, a change in BNP level of Ͻ 20% between baseline and a 2-h SBT predicted extubation success with a sensitivity of 91% and positive predictive value of 97%. Incorporating this threshold value of BNP into the routine SBT in a subsequent validation study increased the extubation success rate from 78% to 95%. 45 Even though the above studies did not focus entirely on the HRFF population, these tools could be valuable in this population, which is more likely to have left (systolic and diastolic dysfunction) and right heart dysfunction.
Point-of-care ultrasonography is now commonly used in many ICUs. There has been increased interest in using bedside transthoracic echocardiography to identify subclinical heart failure during weaning trials. [49] [50] [51] [52] Studies have shown that assessment of early diastolic mitral inflow (E), late diastolic mitral inflow (A), and early diastolic mitral annular velocity (EЈ) using tissue Doppler imaging and the resulting E/A and E/EЈ ratios correlate with the left ventricular filling pressure. [50] [51] [52] In a group of subjects who had previously failed SBTs, a combination of E/A Ͼ 0.95 and E/EЈ Ͼ 8.5 at the end of an SBT trial predicted weaninginduced elevation in pulmonary artery occlusion pressure (Ն 18 mm Hg) with 82% sensitivity and 91% specificity. 50 In a small study of mechanically ventilated subjects, an E/EЈ cutoff value of 14.5 during an SBT trial had a sensitivity of 75% and specificity of 95.8% in predicting failure of extubation (4/20 subjects) or failure of SBT (16/20 subjects) . 53 Further studies with focus on HRFF patients could establish ultrasound as a very useful tool during the SBT assessment.
Arterial Blood Gas Measured at the End of an SBT in HRFF Patients Aids in Identifying Those Who Would Benefit From Noninvasive Ventilation
In subjects with chronic respiratory disorders who tolerated an SBT but had a P aCO 2 of Ͼ 45 mm Hg at the end of an SBT trial, use of prophylactic noninvasive ventilation (NIV) compared to standard therapy decreased postextubation respiratory failure (15% vs 48%) and 90-d mortality (11% vs 31%). 54 Similarly, another study with a significant number of HRFF subjects (80% of Ͼ 65 y of age, 33% with heart failure, and 51% with chronic respiratory disorders) showed decreased postextubation respiratory failure and ICU mortality with prophylactic NIV (in the subgroup analysis, the difference was statistically significant only in subjects with hypercapnia during the SBT). 55 These studies did not show a difference in reintubation rates between the prophylactic NIV and standard therapy groups (most subjects were treated with rescue NIV) due to the small number of re-intubated subjects in both groups. Further studies are needed to evaluate the benefit of NIV in HRFF patients. However, based on the available evidence, it may be prudent to perform an arterial blood gas analysis at the end of the SBT in those HRFF patients with advanced cardiac or pulmonary disease. In those who are found to be hypercapnic, use of prophylactic NIV postextubation could facilitate the weaning process by decreasing the risk of re-intubation and ventilator-associated complications.
Conclusions
Weaning HRFF patients from mechanical ventilatory support is a complex clinical problem. Patients who are elderly or who have chronic respiratory disease and/or heart failure are at increased risk for extubation failure and Fig. 1 . Weaning strategy for the high-risk-for-failure (HRFF) population. Solid lines ϭ main algorithm; dashed lines ϭ optional algorithm. RSBI ϭ rapid shallow breathing index; BNP ϭ serum brain natriuretic peptide; ABG ϭ arterial blood gas; NIV ϭ noninvasive ventilation; E/EЈ ϭ early diastolic mitral inflow/early diastolic mitral annular velocity.
may benefit from management with a weaning algorithm specifically tailored to minimize the risk for postextubation respiratory failure and need for re-intubation (Fig. 1) . Extubation failure has been shown to be associated with an increase in mortality related to re-intubation and the complications that develop after re-intubation. If extubated prematurely, these patients may have difficulty tolerating the increased work of breathing secondary to laryngeal edema, dynamic hyperinflation of lungs, and cardiac overload (systolic and diastolic dysfunction). An SBT in these patients should be performed using a T-piece, which is the best method to replicate the conditions they will experience postextubation. Weaning trials should be performed for a longer duration (120 min) in HRFF patients. Measurement of the RSBI in these patients should be performed off ventilatory support using a spirometer to produce more reliable measurements. Central venous oxygen and BNP measurements and bedside transthoracic echocardiography with tissue Doppler imaging could be useful adjunctive tools to assess subclinical heart failure during an SBT. In a select population, performing an arterial blood gas analysis at the end of the SBT may help identify those who could benefit from prophylactic application of NIV immediately postextubation.
